CD24, TOP2A, IQGAP3, UBE2C, and CRH mRNA levels were also significantly higher in patients with NMIBC than in those with hematuria, which may indicate that they could be used as discriminative biomarkers for BCa detection compared to urological diseases. This evidence concerns the gene UBE2C and urinary system disorder.